Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $18.6 million.

  • MDxHealth's Share-based Compensation rose 1327.01% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 1327.01%. This contributed to the annual value of $17.1 million for FY2024, which is 4106.6% up from last year.
  • MDxHealth's Share-based Compensation amounted to $18.6 million in Q3 2025, which was up 1327.01% from $18.2 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Share-based Compensation ranged from a high of $18.6 million in Q3 2025 and a low of $132000.0 during Q1 2022
  • For the 5-year period, MDxHealth's Share-based Compensation averaged around $10.6 million, with its median value being $11.8 million (2023).
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 603204.42% in 2022, then tumbled by 9451.36% in 2024.
  • Over the past 5 years, MDxHealth's Share-based Compensation (Quarter) stood at $555000.0 in 2021, then surged by 1967.39% to $11.5 million in 2022, then rose by 5.8% to $12.1 million in 2023, then plummeted by 94.51% to $666000.0 in 2024, then soared by 2699.1% to $18.6 million in 2025.
  • Its last three reported values are $18.6 million in Q3 2025, $18.2 million for Q2 2025, and $17.5 million during Q1 2025.